News | May 15, 2015

Company working with CMS to clarify new CPT code for electronic brachytherapy for non-melanoma skin cancers

iCAD, Medicare, resimbursement, CPT, brachytherapy, non-melanoma skin cancers

May 15, 2015 — iCAD Inc. announced that Noridian, the Medicare administrative contractor in Jurisdictions E and F, has made recent web postings related to Coding for High Dose Rate Brachytherapy for Non-Melanoma Skin Cancers. These postings instruct physicians to report CPT code (17999) rather than the established CPT code (0182T) for electronic brachytherapy for non-melanoma skin cancers. Jurisdictions E and F consist of 13 states primarily on the West Coast.

iCAD, industry partners and physician providers have reached out to the Centers for Medicare and Medicaid Services ("CMS") and Noridian to seek clarification of the Medicare Coverage Articles posted to Noridian's web sites.

The company is proactively addressing the situation in its dialogue with Noridian and CMS. At this point, there is insufficient clarification of the reimbursement matter to assess the potential impact that this matter could have on the company's guidance for 2015. Any significant changes in CPT reimbursement from current levels could have a material impact on iCAD’s revenues.

For more information: www.icadmed.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Remanufactured Refurbished Equipment

Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...

Time January 23, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
Sponsored Content | Videos | Radiology Business

Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...

Time November 11, 2025
arrow
News | Interventional Radiology

Nov. 10, 2025 — Interventional radiologists (IRs) that almost exclusively practice in their specialty provide more ...

Time November 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now